Biocon Partners with a Canadian Company to Develop a Diabetic Medication
Biocon Ltd announced on 6 October that it has inked a deal with Juno Pharmaceuticals, a Canadian specialized corporation
In 2023, the pharmaceutical sector is anticipated to be worth $1.5 trillion. Revenue in the worldwide market is expected to reach $1,115 billion.
are the biggest market, with a predicted market volume of $188.2 billion.